XML 87 R78.htm IDEA: XBRL DOCUMENT v3.23.2
Derivative Instruments and Hedging Activities - Impact and Location of Derivative Instruments for Derivatives Designated as Cash Flow Hedging and the Related Components Excluded From Effectiveness Testing (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Aug. 04, 2023
Jul. 29, 2022
Aug. 04, 2023
Jul. 29, 2022
Derivative Instruments, Gain (Loss) [Line Items]        
Net sales $ 1,081,784 $ 1,160,550 $ 3,569,950 $ 3,342,678
Cost of Sales (709,430) (760,644) (2,321,951) (2,236,927)
Cash flow hedging        
Derivative Instruments, Gain (Loss) [Line Items]        
Amount of gain reclassified from AOCL into earnings 3,180 1,840 12,759 1,595
Net Sales | Cash flow hedging        
Derivative Instruments, Gain (Loss) [Line Items]        
Net sales 1,081,784 1,160,550 3,569,950 3,342,678
Cost of Sales | Cash flow hedging        
Derivative Instruments, Gain (Loss) [Line Items]        
Cost of Sales (709,430) (760,644) (2,321,951) (2,236,927)
Forward currency contracts | Net Sales | Cash flow hedging        
Derivative Instruments, Gain (Loss) [Line Items]        
Amount of gain reclassified from AOCL into earnings 1,962 1,640 9,723 1,431
Gain (loss) on components excluded from effectiveness testing recognized in earnings based on changes in fair value (356) 646 2,036 (930)
Forward currency contracts | Cost of Sales | Cash flow hedging        
Derivative Instruments, Gain (Loss) [Line Items]        
Amount of gain reclassified from AOCL into earnings 1,218 200 3,036 164
Gain (loss) on components excluded from effectiveness testing recognized in earnings based on changes in fair value $ 762 $ 627 $ 1,777 $ 1,180